Riyadh Dubai Beirut info@ccho-ma.com
LinkedIn
CCHO – Access to Medicine

Real World Evidence

Clinical trials show how a treatment performs in controlled conditions. Real-world evidence shows how it performs in everyday practice, with the region’s own patients and hospitals.

We analyze real-world data (RWD) and generate real-world evidence (RWE) across the product lifecycle, from launch readiness to post-marketing. We work with large insurance claims databases across the MENA region, covering more than 5 million patients and 17 million claims a year, as well as medical charts and patient-reported outcome and experience measures (PROMs and PREMs). We have run studies in more than 20 disease and therapeutic areas.

Integrated Evidence Planning (IEP)

CCHO’s holistic, dynamic, and proactive approach encompasses the entire product lifecycle, from clinical development to launch and post-marketing activities, integrating RWE and clinical evidence generation and utilization strategies to support your clinical and access objectives. We ensure seamless multi-disciplinary stakeholder engagement and coordination across all activities to provide alignment of global and regional strategies.

We take our partners on the RWE journey from initial evidence gap analysis and protocol design through study implementation and evidence dissemination, with the aim to establish and communicate the real-world value of their products.

1Evidence gap analysisWhere the value story needs proof
2Protocol designStudy, framework and data sources
3Study implementationSites, recruitment, data collection
4Evidence disseminationManuscripts, abstracts, posters
ResultReal-world value communicatedTo payers, HTAs and clinicians

Real-World Data (RWD) Analysis

Retrospective RWE studies utilize and analyze RWD collected from routine clinical practice or administrative sources to evaluate treatment outcomes, healthcare utilization patterns, and patient characteristics. RWD is increasingly used to inform healthcare decisions, particularly for rare disease approvals and expanded indications.

CCHO leverages a diverse range of RWD sources, including:

Electronic health records (EHRs)
Insurance billing and claims databases
Administrative and hospital databases
Established drug or disease registries
Patient-reported outcomes (PROs) and health surveys
Wearable devices and mobile health apps

Real-World Evidence (RWE) Generation

Our RWE generation services are designed to deliver robust insights into the effectiveness, safety, and value of healthcare products in real-world settings. CCHO guides you through every step of your RWE journey, starting by understanding your needs and objectives and designing the optimal study, to developing the protocol, establishing the analytical framework, identifying data sources, managing sites, patient recruitment, and data collection, and supporting your communications needs by developing manuscripts, abstracts, and posters.

We conduct various types of studies including:

  • Prospective drug / disease registries
  • Burden of disease
  • Patient-reported outcome measures (PROMs)
  • Treatment and population trends
  • Cost and healthcare resource utilization (HCRU) analysis

Evidence Synthesis and Evaluation

  • Systematic and targeted literature review
  • Network meta-analysis

See CCHO’s studies in the region

Every project is designed around your objectives.

Book a Complimentary Consultation

Tell us about your evidence or access challenge in the MENA region. We reply within two business days.